CHLAMYDIA TRACHOMATIS IGG ANTIBODIES

The Chlamydia trachomatis IgG Antibodies Test is a specialized blood test that detects Immunoglobulin G (IgG) antibodies produced by the immune system following infection with Chlamydia trachomatis, one of the most common bacterial causes of sexually transmitted infections (STIs) worldwide. This test is primarily used to identify previous exposure, past infection, or chronic Chlamydia infection and to assess the body's immune response.

Chlamydia trachomatis commonly infects the cervix, urethra, rectum, throat, and eyes. Many infected individuals have no symptoms, allowing the infection to spread unnoticed. Untreated infections can result in serious complications, including pelvic inflammatory disease (PID), infertility, ectopic pregnancy, chronic pelvic pain in women, and epididymitis or infertility in men.

Following infection, the immune system first produces IgM antibodies, followed by IgA and IgG antibodies. IgG antibodies usually develop several weeks after infection and may remain detectable for months or even years. Therefore, a positive IgG result generally reflects past exposure or a previous infection rather than confirming an active infection.

The Chlamydia trachomatis IgG Antibody Test is often requested together with Chlamydia trachomatis IgM, IgA antibody tests, and Nucleic Acid Amplification Tests (NAATs/PCR) for a comprehensive evaluation. While NAAT (PCR) remains the gold standard for diagnosing active Chlamydia infection, IgG antibody testing provides useful information about previous infection and long-term immune response.

Benefits of the Test

• Detects Chlamydia trachomatis IgG antibodies
• Helps identify previous exposure to Chlamydia
• Supports evaluation of chronic or past infection
• Assists in infertility investigations
• Complements PCR and other antibody tests
• Requires only a peripheral blood sample
• Supports comprehensive STI evaluation

Why Doctors Recommend This Test

Doctors may recommend this test for individuals with:

• History of Chlamydia infection
• Chronic pelvic pain
• Infertility evaluation
• Recurrent genital infections
• Pelvic inflammatory disease (PID)
• Persistent genital symptoms
• Previous sexually transmitted infections
• Suspected chronic Chlamydia infection
• Recurrent urethritis or cervicitis
• Long-term reproductive health assessment

Preparation Before Test

Sample Required

• Peripheral venous blood sample (Serum)

Preparation Guidelines

• No fasting is required.
• Continue prescribed medications unless advised otherwise by your physician.
• Inform your healthcare provider about previous Chlamydia infections, antibiotic treatment, fertility concerns, or ongoing symptoms.
• Follow laboratory instructions before sample collection.

Reporting Time

Results are generally available within 3–7 working days, depending on laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected previous Chlamydia infection
• Patients undergoing infertility evaluation
• Women with chronic pelvic inflammatory disease
• Men with recurrent urethritis or epididymitis
• Individuals with a history of sexually transmitted infections
• Patients referred by gynecologists, urologists, fertility specialists, infectious disease specialists, or physicians

Clinical Significance

A positive Chlamydia trachomatis IgG antibody result may indicate:

• Previous Chlamydia trachomatis infection
• Past exposure to Chlamydia
• Chronic or persistent infection (when correlated with other findings)
• Long-term immune response

Common symptoms associated with Chlamydia infection include:

• Painful urination
• Vaginal discharge
• Penile discharge
• Pelvic pain
• Lower abdominal pain
• Pain during sexual intercourse
• Testicular pain or swelling
• Rectal discomfort or discharge

A positive IgG result indicates previous exposure or infection but does not confirm an active infection. The result should always be interpreted together with the patient's clinical history, physical examination, IgM and IgA antibody results, and NAAT (PCR) findings. If active infection is suspected, molecular testing is recommended for confirmation.